Updates

May 2012
The renewed image of Ali Raif İlaç Sanayi A.Ş.
The launch of a new anti-depressant product
The launching organization of anti-depressant product that van be used to heal “depression and all anxiety disorders” towards central nervous system market was taken place in İstanbul in February and product was presented to Turkish Medicine market.
May 2011
A new brand from Ali Raif Pharmaceutical

Nepitin that includes gabapentin, as a antiepileptic agent is launced on may 2011. It is use to be treatment of neuropathic pain. Nepitin has two forms, both 600 mg and 800 mg with 50 scored tablets.

Neuropathic pain is a chronic pain that occured as a result of damage of nerves. These damaged nerves fibers send incorrect signals to other pain centers.It affects the quality of life negatively. Major symptoms for neuropathic pain may include shooting and burning pain, tingling and numbness.

The mainly indications of Nepitin are:

  • painful diabetic neuropatic
  • postherpetic neuralgy
  • neuropatic pain after spinalcord damage and
  • epilepsy treatment for older than 12 y.
November 2008
Here comes the difference of ARIS with its new generation antiphychotic which provides a safe and efficient treatment for schizophrenia and bipolar depression.
Especially with its high dose alternative, it offers an opportunity of taking just one single dose in a day.The antiphychotic is at service of Turkish Medicine with its usage alternatives in acute and maintenance treatment of schizophrenia; psychosis with positive and negative symptoms and acute mania attacks related with bipolar I depressions.
November 2008
The major option in treatment of childhood cholestatic liver diseases is now in Turkey!
Cholestatic liver diseases especially in newborns' can progress to liver failure threatening seriously lives. Suspension form of bile acid used as the major treatment option in these patients is at service of Turkish Medicine. High viscose suspension has lemon aroma and includes a beaker that simplifies the application in order to enable dose adjustment.
9-11 June 2008
The new technology in oral antidiabetic drug...
Our oral antidiabetic agent that we have been marketing since 1992, was launched with its new MR (modified release) formulation. This product which increases patient compliance with once a day dosing, regulates blood glucose level by stimulating the release of insulin.
03 May 2008
One More a New Product
A new product as an analgesic – anti-inflammatory plaster ( patch) has been presented to Turkish pharmaceutical market by Ali Raif Pharmaceutical. It includes diclofenac epolamine ( DHEP) is a new salt of diclofenac and a good analgesic - anti-inflammatory effect.

Every patch size is 10cm x 14 cm. A new diclofenac salt ( DHEP) has been prepared and a new pharmaceutical topical formulation, DHEP plaster, has recently been developed with aim of selectively delivering diclofenac to the site of inflammation in order to obtain a targeted and localized therapeutic effect. This formulation consists of a gel base containing DHEP added to an adhesive cloth-based pad which is applied directly onto the affected area.

DHEP Plaster is indicated at the ;
  • short-term symptomatic treatment of attacks of pain on osteoartritis of the knee
  • symptomatic treatment of tendinopathy in the upper and lower limbs
  • symptomatic treatment of benign trauma:sprains, bruises
2 - 10 November 2007
We launched three new products by a meeting in Marmaris on November 02 – 10, 2007
An analgesic and anti – inflammatory product which protects the stomach at the same time; a muscle relaxant for the treatment of painful muscle spasms and an anti – hypertensive product for the treatment of hypertension were launched by ARIS.
02.04.2007
Our Website Renovated:
With our contemporary approach that throws bridges to the future without losing the values of the past, feeling the honor of being one of the firms that grew the most in the year 2006, we will from now on communicate our suggestions “adding value to life” for the long and healthy lives of the 21st century over our renovated website, while continuing to contribute to social health consciousness.
25-28.02.2007
We Launch Our Product for Central Nervous System:
The launch meeting of the antidepressant product that may be used for “depression and all anxiety disorders” intended for central nervous system disorders, was held in Istanbul in February and the product was offered for the service of Turkish medicine.
The renewed logo of Ali Raif İlaç Sanayi A.Ş.: ARIS
As a result of the corporate identity operations that have been in progress for a while, Ali Raif İlaç Sanayi A.Ş. created its new logo from its initials.